[Chronic obstructive pulmonary disease and associated comorbidities].
Bai-qiang
BQ
Cai
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000453:epidemiology*; D015897:Comorbidity; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects; D006333:Heart Failure / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy / Q000453:epidemiology*; D029424:Pulmonary Disease, Chronic Obstructive / Q000453:epidemiology* / Q000628:therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy / Q000453:epidemiology*; D012307:Risk Factors; D012720:Severity of Illness Index
D000319:Adrenergic beta-Antagonists; D000900:Anti-Bacterial Agents; D005938:Glucocorticoids